Our website use cookies to improve and personalize your experience and to display advertisements (if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, and Youtube. By using the website, you consent to the use of cookies.

Four cases of ‘Indian variant’ in South Africa

Four cases of ‘Indian variant’ in South Africa

SOUTH Africa has detected the first four cases of a new coronavirus variant that emerged in India and was responsible for a surge of infections and deaths in the Asian country. Testing had also picked up 11 cases of the variant B.1.1.7 first detected in the UK, the health ministry said in a statement. "The Network for Genomic Surveillance in South Africa confirmed today that two variants of concern, other than the B.1.351 already dominating in South Africa, have been detected," Health Minister Zweli Mkhize said. The four positive cases were detected in Gauteng and KwaZulu-Natal provinces, and all had…
Read More
Results from Novavax vaccine trials in the UK and South Africa differ: why, and does it matter?

Results from Novavax vaccine trials in the UK and South Africa differ: why, and does it matter?

To fast track the response to the COVID-19 pandemic, a broad range of candidate COVID-19 vaccines are being investigated. The results of clinical trials being run on some of them have started to be released. The Novavax vaccine trial is one of them. Phase 3 trial results from the UK and phase 2b results from South Africa were recently announced. Shabir Madhi was the lead researcher in the South African leg of the trial. The Conversation Africa’s Ina Skosana asked him to provide context. SHABIR A. MADHI, Professor of Vaccinology and Director of the SAMRC Vaccines and Infectious Diseases Analytical…
Read More